Facility Overview
The Comprehensive Genomics Shared Resource provides a wide range of cost efficient sequencing services to support precision medicine initiatives and genomics-based applications as well as innovative services that are not readily available to cancer researchers, namely single primer enrichment and long-read sequencing technologies, 10x genomics instruments, and hybrid capture-based panels for targeted DNA and RNA sequencing of clinical tumor and other cancer research tumor samples. The staff of the CLIA-certified, CAP-accredited Clinical Genomics lab has extensive experience in molecular diagnostics and clinical research, and specializes in clinical biomarker discovery, validation, and diagnostic test development. Princeton University is a consortium member institution of the Rutgers Cancer Institute. Cancer Center members may be eligible for priority access and rate subsidies for shared resources supported by the Cancer Center Support Grant (P30CA072720) from the National Cancer Institute.
Website:
Point of Contact:
Sequencing & QC/QA
Milind Mahajan
[email protected]
CytAssist
Ankit Saxena
[email protected]
Open to:
Available to Princeton University researchers as a member institution.